Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
08/2005
08/18/2005WO2005075459A1 Synthesis of cyanoimino-benzoimidazoles
08/18/2005WO2005074872A1 Lightening direct dyestuffs for keratin fibers and dyes containing said compounds
08/18/2005US20050182082 Modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/18/2005CA2555219A1 Synthesis of cyanoimino-benzoimidazoles
08/17/2005EP1562943A1 Fused heterocyclic compounds
08/17/2005EP1562593A2 Topoisomerase-targeting agents
08/17/2005EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/11/2005WO2005073204A1 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
08/11/2005WO2005072732A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005US20050176970 Field-effect transistor; mono- and diimide perylene and naphthalene compounds, core-substituted with one or more electron-withdrawing groups, generating the radical anions electrochemically
08/11/2005US20050176780 2,5-disubstituted 3-mercaptopentanoic acid
08/11/2005US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation
08/11/2005US20050176718 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
08/11/2005US20050176702 1,8-Annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
08/11/2005DE102004003735A1 Verfahren zur Herstellung von Terrylen-3,4:11,12-tetracarbonsäurediimiden Process for preparing terylene-3,4: 11,12-tetracarboxylic
08/11/2005DE102004003734A1 Verfahren zur Herstellung von Terrylen-3,4:11,12-tetracarbonsäurediimiden durch Di-rektsynthese Process for preparing terylene-3,4: 11,12-tetracarboxylic by di-rektsynthese
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/09/2005US6927294 Nitrogen-containing heterocycles
08/09/2005CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
08/04/2005WO2005070895A1 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis
08/04/2005WO2005070894A1 Method for producing terrylen-3,4:11,12-tetracarbon acid di-imids
08/04/2005WO2004091485A3 Aminoquinoline compounds
08/04/2005US20050171355 important intermediate; without using an expensive catalyst and a special facilities; reacting a pyrimidinium derivative such as 1,3-dimethyl-2,3-dihydro-2-oxopyrimidinium chloride, an acetyl compound such as 4-acetylpyridine and an ammonia or an ammonium salt
08/04/2005US20050171352 Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine)
08/04/2005US20050171252 provides protection from the damaging effects of light, and at least one organic material; Living and inanimate organic material such as human or animal skin, human or animal hair, paper, foods, perfumes, cosmetics, plastics, polymer dispersions, paints, photographic emulsions, photographic layers, etc
08/04/2005US20050171102 Semicarbazide derivatives for combating thromboembolic diseases
08/04/2005US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone
08/03/2005EP1559711A1 Preparation of pyridine derivatives using pyrimidinium derivatives as intermediates
08/03/2005EP1558576A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
08/03/2005EP1558250A1 Gamma-aminoamide modulators of chemokine receptor activity
08/03/2005CN1649967A Method for the production of perylen-3, 4:9, 10-tetracarboxylic acid diimides and perylen-3, 4:9, 10-tetracarboxylic acid dianhydride and naphtalene-1, 8-dicarboxylimides
08/03/2005CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/03/2005CN1649845A Muscarinic antagonists
08/02/2005US6923836 Preparation of dyed plastics or polymeric dye particles
08/02/2005CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
07/2005
07/28/2005US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
07/28/2005US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides
07/28/2005DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
07/27/2005EP1557410A2 Bacterial gyrase inhibitors and uses thereof
07/27/2005EP1556382A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
07/27/2005EP1556358A2 Enantioselective alkylation of tricyclic compounds
07/27/2005EP1287004B1 Synthetic process for the manufacture of an ecteinascidin compound
07/27/2005EP1274411B1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
07/27/2005CN1212318C Fluorene-naphthalene imide derivative compound and its application
07/26/2005US6921835 Carbocyclic carboxy amines such as 1-aminomethyl-3,4-dimethyl-cyclopentyl acetic acid or prodrugs used as antiepileptics, antidepressants, anxiolytics, analgesics, antiinflammatory agents and for prophylaxis of neurodegenerative disorders
07/26/2005US6921759 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV
07/26/2005CA2253948C Carboline derivatives
07/26/2005CA2149007C Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases
07/21/2005WO2005065779A1 Calcitonin gene related peptide receptor antagonists
07/21/2005WO2005043124A3 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
07/21/2005WO2005018561A3 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
07/21/2005US20050159487 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
07/21/2005US20050159440 N-substituted groups such as 3-fluoropropyl; 2,2-dimethylethyl; 2-ethoxyethyl; 2-methoxyethyl; 2-propenyl; 2-propynyl; 2-cyanoethyl; 3-cyanopropyl; 3-iodoprop-(2E)-enyl; 3-iodoprop-(2Z)-enyl; therapy for drug abuse, in particular, cocaine abuse; side effect reduction
07/21/2005CA2549330A1 Calcitonin gene related peptide receptor antagonists
07/20/2005EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands
07/20/2005EP1185493B1 Quinones for treatment of diseases
07/20/2005EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
07/20/2005CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
07/20/2005CN1640869A Method for preparing 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo[a, d]-5-cycloheptanone
07/20/2005CN1211386C Antitumoral analogue of Et-743
07/19/2005US6919445 Detecting with a multicolor fluorescent dyes, for automated 4-DNA sequencing systems, identifying the classes of the polynucleotides
07/14/2005WO2005063680A1 Process for the preparation of arylamines
07/14/2005WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005WO2005062894A2 Co-administration of dopamine-receptor binding compounds
07/14/2005US20050153997 Fredericamycin derivatives
07/14/2005US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof
07/14/2005CA2550650A1 Co-administration of dopamine-receptor binding compounds
07/14/2005CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/13/2005CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
07/13/2005CN1636982A Synthesis of intermediates useful in preparing tricyclic compounds
07/12/2005US6916830 Substituted tetrahydroisoquinolines as C5a receptor modulators
07/12/2005US6916823 Method of treatment of dopamine-related dysfunction
07/07/2005WO2005047258A3 Methods and compositions for selectin inhibition
07/07/2005WO2004048340A8 Sinomenine and sinomenine compounds, synthesis and use
07/07/2005US20050148591 Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof
07/07/2005CA2548494A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
07/07/2005CA2547814A1 Spiropiperidine derivatives for controlling pests
07/06/2005EP1280809B1 Antitumoral ecteinascidin derivatives
07/06/2005CN1635998A Tricyclic analgesics
07/06/2005CN1634894A Spiro[benzocyclo-4'-piperidine-2'-one] template compound and method for preparing same
07/06/2005CN1634893A 4, 5-disubstituted-1, 8-naphthoyl imide compounds and use thereof
06/2005
06/30/2005WO2005058836A1 Insecticidal spiroindane derivatives
06/30/2005WO2005058298A2 Fk228 analogs and their use as hdac-inhibitors
06/30/2005WO2004089926A3 Genipin derivatives and uses thereof
06/30/2005US20050143408 Aporphine esters and their use in therapy
06/30/2005CA2557004A1 Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
06/29/2005EP1545502A2 Keto cannabinoids with therapeutic indications
06/29/2005EP1373272B1 Tert. alkylphenoxy substituted polycyclic compounds
06/29/2005CN1633472A Thermochromic rylene dyes
06/29/2005CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
06/23/2005WO2004089307A8 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
06/22/2005EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542983A1 Heterodiamondoids
06/22/2005EP1542975A2 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides
06/22/2005CN1630641A Farnesyl protein transferase inhibitors as antitumor agents
06/22/2005CN1630639A Novel pyridine- and quinoline-derivatives
06/22/2005CN1207285C Method of extracting Huperzine A from Chinese herbal medicine multi-layer tower
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 110